skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: SU-G-IeP4-05: Experience with a Practical Approach to the Release of Radioactive Patients from Radiation Safety Isolation

Abstract

Purpose: The radioactive patient releases of the nuclear medicine department in a large cancer center were analyzed to compare the estimated doses to others to the regulatory limit and institutional targets and to gauge how onerous the patients’ instructions were. Methods: In-house software that implements the NUREG 1556 approach and further considers fellow travelers, children and pregnant women and members of the public following Siegel, et al., is used to calculate release timing and to provide patients with individualized instructions. A retrospective analysis of the 218 releases in 2015 that required instructions included all I-131 and Lu-177 treatments. Results: There were 87 male and 131 female patients. They were 45.5±16.5 (8-84) years old, weighed 83.3±21.8 kg and stood 168±10 cm tall with a body mass index of 29.3±6.7 kg/m2. 195 patients received 2.96±2.23 GBq of I-131-NaI for differentiated thyroid carcinoma and eight received 636±231 MBq of I-131-NaI for hyperthyroidism. There were eight administrations of 18.5 GBq of I-131-mIBG and seven administrations of 7.4 GBq of Lu-177-DOTATATE. The dose to the most exposed person was 1.67±1.05 (mode=0.60, median=1.15) mSv. The dose to a fellow traveler was 0.31±0.31 (mode=0.1, median=0.17) mSv. The dose to children and pregnant women was 0.51±0.34 (mode=1.0, median=0.42)more » mSv. The duration of isolation was 7.7±17.3 (mode=2, median=1.7) hours. The duration of sleeping alone was 60.4±127 (mode=0, median=15.5) hours. The time to delay traveling was 12.2±11 (mode=median=0) hours. The time to completely avoid children and pregnant women was 23.3±26.5 (0–254, mode=median=24) hours followed by limited contact for 20.6±68.1 (0–491, mode=median=0) hours. The time to avoid others (e.g., to wait to return to work) was 12.1±101 (0–1465, mode=median=0) hours. Conclusion: The estimated doses to others were often well below the limits set by regulation, 5 mSv, or prudent practice, 1 mSv. Most patients’ instructions were not hard to comply with.« less

Authors:
; ; ; ; ; ;  [1]
  1. UT MD Anderson Cancer Center, Houston, TX (United States)
Publication Date:
OSTI Identifier:
22649440
Resource Type:
Journal Article
Resource Relation:
Journal Name: Medical Physics; Journal Volume: 43; Journal Issue: 6; Other Information: (c) 2016 American Association of Physicists in Medicine; Country of input: International Atomic Energy Agency (IAEA)
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; 61 RADIATION PROTECTION AND DOSIMETRY; CHILDREN; COMPUTER CODES; DOSES; IODINE 131; LUTETIUM 177; PATIENTS; RADIATION PROTECTION; WOMEN

Citation Formats

Wendt, R, Erwin, W, Fisher, A, Jones, S, Jimenez, S, Wong, F, and Jessop, A. SU-G-IeP4-05: Experience with a Practical Approach to the Release of Radioactive Patients from Radiation Safety Isolation. United States: N. p., 2016. Web. doi:10.1118/1.4957100.
Wendt, R, Erwin, W, Fisher, A, Jones, S, Jimenez, S, Wong, F, & Jessop, A. SU-G-IeP4-05: Experience with a Practical Approach to the Release of Radioactive Patients from Radiation Safety Isolation. United States. doi:10.1118/1.4957100.
Wendt, R, Erwin, W, Fisher, A, Jones, S, Jimenez, S, Wong, F, and Jessop, A. 2016. "SU-G-IeP4-05: Experience with a Practical Approach to the Release of Radioactive Patients from Radiation Safety Isolation". United States. doi:10.1118/1.4957100.
@article{osti_22649440,
title = {SU-G-IeP4-05: Experience with a Practical Approach to the Release of Radioactive Patients from Radiation Safety Isolation},
author = {Wendt, R and Erwin, W and Fisher, A and Jones, S and Jimenez, S and Wong, F and Jessop, A},
abstractNote = {Purpose: The radioactive patient releases of the nuclear medicine department in a large cancer center were analyzed to compare the estimated doses to others to the regulatory limit and institutional targets and to gauge how onerous the patients’ instructions were. Methods: In-house software that implements the NUREG 1556 approach and further considers fellow travelers, children and pregnant women and members of the public following Siegel, et al., is used to calculate release timing and to provide patients with individualized instructions. A retrospective analysis of the 218 releases in 2015 that required instructions included all I-131 and Lu-177 treatments. Results: There were 87 male and 131 female patients. They were 45.5±16.5 (8-84) years old, weighed 83.3±21.8 kg and stood 168±10 cm tall with a body mass index of 29.3±6.7 kg/m2. 195 patients received 2.96±2.23 GBq of I-131-NaI for differentiated thyroid carcinoma and eight received 636±231 MBq of I-131-NaI for hyperthyroidism. There were eight administrations of 18.5 GBq of I-131-mIBG and seven administrations of 7.4 GBq of Lu-177-DOTATATE. The dose to the most exposed person was 1.67±1.05 (mode=0.60, median=1.15) mSv. The dose to a fellow traveler was 0.31±0.31 (mode=0.1, median=0.17) mSv. The dose to children and pregnant women was 0.51±0.34 (mode=1.0, median=0.42) mSv. The duration of isolation was 7.7±17.3 (mode=2, median=1.7) hours. The duration of sleeping alone was 60.4±127 (mode=0, median=15.5) hours. The time to delay traveling was 12.2±11 (mode=median=0) hours. The time to completely avoid children and pregnant women was 23.3±26.5 (0–254, mode=median=24) hours followed by limited contact for 20.6±68.1 (0–491, mode=median=0) hours. The time to avoid others (e.g., to wait to return to work) was 12.1±101 (0–1465, mode=median=0) hours. Conclusion: The estimated doses to others were often well below the limits set by regulation, 5 mSv, or prudent practice, 1 mSv. Most patients’ instructions were not hard to comply with.},
doi = {10.1118/1.4957100},
journal = {Medical Physics},
number = 6,
volume = 43,
place = {United States},
year = 2016,
month = 6
}